Asia-Pacific Rising As a Novel Destination for Developing New Vaccines

Press Release   •   Jun 24, 2013 12:47 IST

Growing vaccines market in Asia Pacific region is giving new dimension to pharmaceutical industry. Varoius companies in the region have adopted most recent technologies and competent production methods to increase vaccines for numerous diseases at inexpensive prices. Also, the Western companies are investing profoundly in the region. Besides, Asia-Pacific region presents huge untapped market potential for several vaccines due to the low immunization rate. Considering the above factors, the Asia-Pacific pharma industry is anticipated to grow at a CAGR of over 10% during 2012-2015.

As per our research report, “Asia Pacific Pharma Sector Analysis”, Asia-Pacific region is emerging as the fastest growing pharmaceutical industry worldwide. The market growth in the region will mainly be driven by factors, like low costs, quality treatment, and less waiting time. Further, on studying the pharmaceutical market in various countries, we observed that mature markets of Japan and Australia are experiencing slower growth rates, while emerging as new market leaders, China and India are enjoying investments by foreign pharmaceutical companies. On the other hand, the western countries are facing the issue of poorly defined regulatory pathways and a few Asian countries are well positioned to benefit from these changes, attracting huge investments by generic companies.The OTC sector in the region has also been expanding rapidly.

Besides, the report provides an in-depth research and rational analysis of the current status and expected position of the Pharma Market in Asia Pacific. It thoroughly examines all prominent emerging trends and drivers, which are fueling growth to the industry’s development. In addition to that, the report presents information on the key competitors in each country in the Asian-Pacific region along with their business details and areas of expertise. It also presents a highly concentrated structure of the market, along with the top players dominating the market. For the purpose of our research we have considered countries viz. Japan, China, India, South Korea, Malaysia, Thailand, Indonesia, Vietnam, Philippines, Australia, and New Zealand. The research will help consultants, industry analysts, and vendors to get an in-depth knowledge of the current, past, and future performance of the industry.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM226.htm

Some of our Related Reports are:

- Global API Market Analysis (http://www.rncos.com/Report/IM320.htm)
- US Nutraceuticals Market Analysis (http://www.rncos.com/Report/IM350.htm)
- Global Telemedicine Market Analysis (http://www.rncos.com/Report/IM331.htm)
- Personalized Medicine Market Analysis (http://www.rncos.com/Report/IM305.htm)
- Global HIV Therapeutics Market Analysis (http://www.rncos.com/Report/IM361.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.